Incoming investment
Published: 25 Nov. 2021, 18:52
![Joachim Kreuzburg, left, CEO of German-based biotech company Sartorius, poses with Incheon mayor Park Nam-choon after a meeting at the G-Tower in Yeonsu District, Incheon, on Thursday. The meeting was held to discuss the $300 million investment pledge made in November for Sartorius to build a biopharmaceutical raw material plant in Songdo, Incheon. The plant will manufacture cell culture media, membrane filters and other raw materials. [INCHEON FREE ECONOMIC ZONE]](https://koreajoongangdaily.joins.com/data/photo/2021/11/25/0d10f429-a2ec-4270-b222-9445340be2fb.jpg)
Joachim Kreuzburg, left, CEO of German-based biotech company Sartorius, poses with Incheon mayor Park Nam-choon after a meeting at the G-Tower in Yeonsu District, Incheon, on Thursday. The meeting was held to discuss the $300 million investment pledge made in November for Sartorius to build a biopharmaceutical raw material plant in Songdo, Incheon. The plant will manufacture cell culture media, membrane filters and other raw materials. [INCHEON FREE ECONOMIC ZONE]
with the Korea JoongAng Daily
To write comments, please log in to one of the accounts.
Standards Board Policy (0/250자)